ArticleDiagnostics (Basel, Switzerland)2025
High-Risk Node-Positive Hormone Receptor-Positive/HER2-Low Breast Cancer Relapse on Adjuvant Abemaciclib Treatment with ER Loss at Metastatic Recurrence: A Case Report and Literature Review.
Maria Vita Sanò et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.